Chinese Hypertension Guidelines
Author:
- 29 April 2015
- journal article
- review article
- Published by S. Karger AG in Pulse
- Vol. 3 (1) , 14-20
Abstract
According to the 4th National Nutrition and Health Survey in 2002, the prevalence of hypertension in China was 18.8%. Although there are no recent updated nationwide data, it is believed that the prevalence of hypertension has increased substantially in the past decade up to more than 200 million hypertensive patients in the populous country of China. To fight against the growing risk of hypertension, three Chinese hypertension guidelines were compiled in the past two decades, in 1999, 2005, and 2011. The current guidance document for the management of hypertension was named ‘2010 Chinese hypertension guideline', but it was actually published in 2011. In this guideline, all five classes of antihypertensive drugs were recommended as possible initial and maintenance therapy. The goal of treatment was a systolic/diastolic blood pressure below 140/90 mm Hg in general, 130/80 mm Hg in various groups of high-risk patients, and 150/90 mm Hg in the elderly (≥65 years). With the recent publication of several national and international hypertension guidelines, the Chinese guideline is now under discussion for updating.Keywords
This publication has 22 references indexed in Scilit:
- Valsartan/Amlodipine Compared to Nifedipine GITS in Patients with Hypertension Inadequately Controlled by MonotherapyAdvances in Therapy, 2013
- 2013 ESH/ESC Guidelines for the management of arterial hypertensionJournal Of Hypertension, 2013
- Prevalence, awareness, treatment and control of hypertension in elderly ChineseHypertension Research, 2013
- Efficacy and Safety of a Fixed Combination of Irbesartan/Hydrochlorothiazide in Chinese Patients with Moderate to Severe HypertensionDrugs in R&D, 2013
- Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders StudyEuropean Heart Journal, 2011
- Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: A scientific statement from the Asian Pacific Heart AssociationHypertension Research, 2011
- 2003 European Society of Hypertension???European Society of Cardiology guidelines for the management of arterial hypertension*Journal Of Hypertension, 2003
- Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertensionJournal Of Hypertension, 1998
- Shanghai trial of nifedipine in the elderlyJournal Of Hypertension, 1996
- Prevalence of hypertension and its trends in Chinese populationsInternational Journal of Cardiology, 1995